Stay updated with breaking news from Aging Brain. Get real-time updates on events, politics, business, and more. Visit us for reliable news and exclusive interviews.
The development and approval of Leqembi, the first FDA-approved medication proven to slow the progression of Alzheimer’s disease, is a milestone. But there is a need to develop drugs with greater effectiveness, and that can be given to more people with AD at a lower cost, writes Lawrence S. Honig.
Breakthrough new drugs that clear amyloid beta plaques from the brain are shaking up the field of Alzheimer's disease research.
MONDAY, July 24, 2023 (HealthDay News) -- Breakthrough new drugs that clear amyloid beta plaques from the brain are shaking up the field of Alzheimer’s disease research.
Older adults who don’t often interact with others may be at higher risk of losing brain volume compared to those who socialize more.
MONDAY, July 17, 2023 (HealthDay News) -- Another experimental drug meant to slow the damage of Alzheimer’s appears poised to join a growing arsenal of new treatments for this memory-robbing